Last year we all sought to adjust to a new normal as the Trump Administration settled in, with the Affordable Care Act (ACA) in its crosshairs. But as our smart and sophisticated 2017 survey respondents predicted, the ACA lives on. For this year’s Healthcare Prognosis, we revisited some topics, like drug pricing and startup health, and added some new questions related to current issues and trends. Once again, we relied on the opinions of a few hundred of the smartest people we know across healthcare.

Read our key findings here.